Company Filing History:
4 out of 4 
1 out of 1 
1 out of 1 Years Active: 2016-2020
Title: The Innovative Contributions of Ross Bersot
Introduction
Ross Bersot, an accomplished inventor based in Orinda, CA, is recognized for his impactful contributions to pharmaceutical sciences. With a portfolio of six patents, his work primarily focuses on developing innovative compounds for the treatment of various diseases and disorders.
Latest Patents
Among his notable patents, Bersot has developed carbazole-containing amides, carbamates, and ureas as cryptochrome modulators. These compounds are designed to target Cry-mediated diseases, providing potential treatment options for conditions such as diabetes, complications related to diabetes, Cushing's syndrome, Non-Alcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease (NAFLD), asthma, and Chronic Obstructive Pulmonary Disease (COPD). Another significant patent involves carbazole-containing sulfonamides, which also serve as cryptochrome modulators. These derivatives aim to address diseases like diabetes, obesity, metabolic syndrome, Cushing's syndrome, and glaucoma, showcasing his innovative approach in the field.
Career Highlights
Bersot has made substantial contributions while working with companies such as Reset Therapeutics, Inc. and Synchronicity Pharma, Inc. His dedication and expertise in pharmaceuticals have established him as a vital contributor to advancements in drug development.
Collaborations
In his journey, Ross Bersot has collaborated with talented professionals in the industry, including his coworker, Paul Humphries. This teamwork has further propelled his innovative research and development efforts.
Conclusion
With a strong foundation in pharmaceutical innovations and a focus on addressing critical health issues, Ross Bersot continues to make noteworthy strides in the medical field. His patents pave the way for potential therapies that may significantly improve the quality of life for many individuals suffering from various diseases.